1 / 9

The United States National Vaccine Plan: Status and Priority Setting, February, 2010

The United States National Vaccine Plan: Status and Priority Setting, February, 2010. Raymond A. Strikas, M.D. National Vaccine Program Office (NVPO) U.S. Department of Health and Human Services. Outline of Presentation. National Vaccine Plan (NVP) Update Current status

halle
Download Presentation

The United States National Vaccine Plan: Status and Priority Setting, February, 2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The United States National Vaccine Plan:Status and Priority Setting, February, 2010 Raymond A. Strikas, M.D. National Vaccine Program Office (NVPO) U.S. Department of Health and Human Services

  2. Outline of Presentation • National Vaccine Plan (NVP) Update • Current status • Timeline for completion • Priorities: IOM, HHS, NVAC

  3. OCT NOV DEC JAN FEB MAR APR MAY JUN JULY AUG SEP National Vaccine Plan Revision TimelineCurrent Activities 2010 OCT NOV HHS/Federal Activities Oct 19 ASH Briefing 2012 Budget Discussions Complete Plan Version 2 with Priorities Complete Final Strategic Plan Complete Implementation Plan NVAC Activities Nov 6 NVAC H1N1 Call Mid Dec NVAC IOM Call Feb 3-4 NVAC Meeting RAND Interviews External Activities/ Stakeholders Nov 30 IOM Report Dec 11 IOM Briefing 8 Weeks Public Comment

  4. Institute of Medicine: Review of Priorities for the National Vaccine Plan Stakeholder Meetings • Goal 4 (July 24, 2008) • Goal 1 (December 1, 2008) • Goal 3 (February 2, 2009) • Goal 2 (April 14, 2009) • Goal 5 (June 4, 2009) • Final report December 11, 2009* *See http://www.iom.edu/Activities/PublicHealth/NatVaxPlan.aspx

  5. Selected Recommendations from 12/11/09 IOM Report on Priorities for the National Vaccine Plan • 1-4: Future iterations of the … Plan should include … therapeutic vaccines and vaccines against non-infectious diseases beyond those … in the statute… • 2-3: The …Plan should include the establishment of a … permanent NVAC vaccine safety subcommittee to provide guidance …; publish … biennial review of potential safety hypotheses; current safety activities…; planned priorities for research

  6. Selected Recommendations from 12/11/09 IOM Report on Priorities for the National Vaccine Plan (2) • 3-1: Develop a national communication strategy on vaccines and immunization for both the public and health care professionals • 4-2: should include … strategies to eliminate financial barriers … in the delivery of immunization services

  7. Selected Recommendations from 12/11/09 IOM Report on Priorities for the National Vaccine Plan (3) • Recommendation 6-1: The Secretary of HHS should actively demonstrate the Department’s support for the National Vaccine Plan by: • (1) clarifying its primacy as the strategic planning tool applicable to all federal agencies with roles in the National Vaccine Program, and • (2) allocating the resources necessary to assure robust planning and implementation, with coordination by the National Vaccine Program office.

  8. NVAC Criteria to Recommend Priorities for the draft strategic National Vaccine Plan • Feasibility (financial and technical) • Potential impact on morbidity and mortality • Strategic opportunity (likely to require, motivate multi-stakeholder involvement) • Public salience (derived from 5 top public engagement priority areas) • Make vaccines affordable and available to everyone. • Maintain high rate of vaccination of children. • Improve monitoring of disease and vaccines. • Improve vaccine safety. • Assure there is enough vaccine.

  9. Discussion

More Related